BioSpace News Archive

Lexaria Bioscience Corp (LXRP:OTCQX LXX:CSE), based in Kelowna, BC, focused on the improved delivery of active pharmaceutical ingredients in food, beverages and topicals, today announced that Chris Bunka, CEO will present live at VirtualInvestorConferences.com on July 11th.

Valens GroWorks Corp. (TSXV: VGW, OTC: VGWCF) (the “Company” or “Valens”), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing, is pleased to confirm it will issue its second quarter financial results,

Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2019 financial results on Tuesday, July 30, 2019.

Wait a Week for a Cold Sore to Go Away? Selfies and Social Media Say No!

New 8-French 25cm Device Receives FDA 510k clearance

CStone Pharmaceuticals announced that the first patient has been dosed in China with avapritinib in the ongoing global Phase III VOYAGER clinical trial.

The Centers for Disease Control and Prevention has found that one in nine women experience symptoms of postpartum depression nationally

Kelyniam Global (KLYG), a maker of custom cranial implants announced today that it has entered into a distribution agreement with Bioplate, Inc., a leading manufacturer of cranial fixation devices for neurosurgery.

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it will report second quarter 2019 results on Tuesday, July 23, 2019, before the market opens.

Children’s Institute, the social impact organization dedicated to transforming the lives of children exposed to adversity and poverty in Los Angeles, released a PSA in English and Spanish today about the short- and long-term effects of childhood trauma.